NCT06715995Recruiting
Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults
Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults: a Randomized, Placebo-controlled, Double-blind Study
Source: ClinicalTrials.gov · Last updated 4 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the effects of endogenous gamma non-flickering light stimulation on resting-state EEG rhythms and cognitive function in cognitively healthy older adults. Specifically, it will assess the immediate and long-term effects of this stimulation on brainwave activity and cognitive performance. The study will explore the potential of gamma light stimulation as a non-pharmacological intervention for cognitive decline in aging populations.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- First submitted
- 28 Nov 2024
- Start date
- 9 Dec 2024
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Alzheimer disease
- NCT number
- NCT06715995
What you commit to
- Study type: Interventional
- Planned participants: 52
- From 9 Dec 2024 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 2\. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.).
Other
- 1\. Participants enrolled in any cognitive enhancement study within the past two months.
- 3\. Pregnant, or planning to become pregnant.
Who the study is looking for
- 1\. Age over 55 years old.
- 2\. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education.
- 3\. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could affect cognitive function.
- 4\. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.).
- 5\. Participants with normal or corrected vision (e.g., glasses or contact lenses) to normal levels.
- 6\. Voluntary to sign the Informed Consent Form.
Age in the registry: 55 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung University Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Recruiting |
Related publications
- A randomized pilot trial of non-flickering 40 Hz light stimulation: EEG activity and cognitive outcomes in cognitively normal older adults.J Alzheimers Dis · 2026 · PMID 42847333
This page is information, not medical advice. Discuss any trial with your doctor.